Measurement of prostate specific antigen and γ-seminoprotein ratio: A new means of distinguishing benign prostatic hyperplasia and prostate cancer

Journal of Urology

Volumn 150, Issue 5 II, 1993, Pages 1740-1745

  Demura, T ^a   Watarai, Y ^a   Togashi, M ^a   Hirano, T ^a   Ohashi, N ^a   Koyanagi, T ^a  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

antigens, neoplasm; prostatic hypertrophy; prostatic neoplasms

Indexed keywords

BIOCHEMICAL MARKER; GAMMA SEMINOPROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; PROTEIN DETERMINATION; TRANSURETHRAL RESECTION;

EID: 0027759218     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(17)35883-4     Document Type: Article

References (22)

1. M.C. Wang L.A. Valenzuela G.P. Murphy T.M. Chu Purification of a human prostate specific antigen Invest. Urol. 17 1979 159
2. M. Kuriyama M.C. Wang L.D. Papsidero C.S. Killian T. Shimano L. Valenzuela T. Nishiura G.P. Murphy T.M. Chu Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay Camcer Res. 40 1980 4658
3. M. Kuriyama M.C. Wang C.L. Lee L.D. Papsidero S. Killian H. Inaji N.H. Slack T. Nishiura G.P. Murphy T.M. Chu Use of human prostate-specific antigen in monitoring prostate cancer Cancer Res. 41 1981 3874
4. P. Guinan R. Bhatti P. Ray An evaluation of prostate specific antigen in prostatic cancer J. Urol. 137 1987 686
5. J.P. Weber J.E. Oesterling C.A. Peters A.W. Partin W. Chan P.C. Walsh The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia J. Urol. 141 1989 987
6. A.W. Partin H.B. Carter D.W. Chan J.I. Epstein J.E. Oesterling R.C. Rock J.P. Weber P.C. Walsh Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia J. Urol 143 1990 747
7. W.J. Catalona D.S. Smith T.L. Ratliff K.M. Dodds D.E. Coplen J.J. Yuan J.A. Petros G.L. Andriole Measurement of prostate-specific antigen in serum as a screening test for prostate cancer New Engl. J. Med. 324 1991 1156
8. J.K. Siddall S.D. Shetty E.H. Cooper Measurement of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate Clin. Chem. 32 1986 2040
9. M. Kuriyama T. Takeuchi I. Shinoda M. Okano T. Nishiura Clinical evaluation of gamma-seminoprotein in prostate cancer Prostate 8 1986 301
10. T. Yoshiki K. Okada K. Oishi O. Yoshida Clinical significance of tumor markers in prostatic carcinoma—comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein Acta Urol. Jap. 33 1987 2044
11. Y. Ishihara Y. Hiromoto Y. Higaki K. Imamura Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer Acta Urol. Jap. 35 1989 409
12. M. Hara T. Inoue Y. Koyanagi J. Goto H. Yamazaki T. Fukuyama Preparation and immunoelectrophoretic assessment of antisera to human seminal plasma Jap. J. Legal Med 20 1966 356
13. H. van Halbeek G.J. Gerwig J.F. Vliegenthart R. Tsuda M. Hara K. Akiyama K. Schmid Occurrence of the Y determinant on the N-glycosidic carbohydrate units of human gamma-seminoprotein Biochem. Biophys. Res. Comm 131 1985 507
14. J. Schaller K. Akiyama R. Tsuda M. Hara T. Marti E.E. Rickli Isolation, characterization and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma Eur. J. Biochem 170 1987 111
15. A. Lundwall H. Lilja Molecular cloning of human prostate specific antigen cDNA FEBS. Letters 214 1987 317
16. K.W.K. Watt P.J. Lee T. M’Timkulu W.P. Chan R. Loor Human prostate-specific antigen: structural and functional similarity with serine proteases Proc. Natl. Acad. Sci 83 1986 3166
17. A. Fujino N. Mukai T. Kawakami E. Yokoyama S. Mashimo T. Endo A. Ishibashi K. Koshiba Y. Aoki H. Itoh Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue Jap. J. Urol. 82 1991 541
18. T.A. Stamey J.N. Kabalin Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients J. Urol. 141 1989 1070
19. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate specific antigen in patients with prostate cancer J. Urol. 142 1989 1011
20. U.-H. Stenman J. Leinonen H. Alfthan S. Rannikko K. Tuhkanen O. Alfthan A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Res. 51 1991 222
21. H. Lilja A.T.K. Cockett P.-A. Abrahamsson Prostate specific antigen predominantly forms a complex with alphai-antichymotrypsin in blood Cancer 70 1992 230
22. K. Kawakami T. Tsukada T. Nakayama Analysis on inhibitory reaction of gamma-Sm, a marker for prostate cancer. Jap J. Clin. Path. 40 suppl 1992 245